JPRN-jRCT2031200425进行中（未招募）未知
An extention study of JR-401 in short stature patients with SHOX deficiency
Ibaraki Ryo0 个研究点目标入组 19 人开始时间: 2021年3月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 19
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •A pediatric Patient who participated in the previous study and completed the visit after 24 months, and who were judged by the principal-investigator or sub-investigator to be safe for transfer to this study from the viewpoint of safety
排除标准
- •A pediatric patient with a diagnosis of diabetes (following the Diagnostic Procedure for Diabetes)
研究者
相似试验
已完成
3 期
A phase III study of JR-401 in patients with SHOX dificiencyShort stature patients with SHOX deficiencyJPRN-jRCT2080223889JCR Pharmaceuticals Co., Ltd.32
招募中
1 期
A study to extend treatment with JR-141 after completion of Study JR-141-GS31Mucopolysaccharidosis II, Hunter SyndromeMedDRA version: 20.1Level: PTClassification code: 10056889Term: Mucopolysaccharidosis II Class: 100000004850CTIS2022-503142-41-00Jcr Pharmaceuticals Co. Ltd.71
进行中（未招募）
2 期
An extension study of phase 2 study of JR-142 in pediatric patients with growth hormone deficiencyGrowth hormone deficiency in childrenJPRN-jRCT2031210366Kanai Aya24
进行中（未招募）
1 期
An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type IMucopolysaccharidosis IJPRN-jRCT2051210040Kawashima Satoshi14
进行中（未招募）
1 期
An extension study of JR-031 in infants with neonatal hypoxic ischemic encephalopathy (hereinafter referred to as nHIE) for which hypothermia therapy is indicatedneonatal hypoxic ischemic encephalopathy (nHIE)JPRN-jRCT2033200293Yamamoto Tatsuyoshi13